Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-Nipah virus/NiV G protein/Glycoprotein G Antibody (nAH1.3)

Catalog #:   VVV07901 Specific References (26) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA, Neutralization
Accession: Q9IH62
Overview

Catalog No.

VVV07901

Species reactivity

Nipah virus (NiV)

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

Glycoprotein G, G

Concentration

2.2 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9IH62

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

nAH1.3

Data Image
References

Novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle. [VVV07901]

Design and Preliminary Immunogenicity Evaluation of Nipah Virus Glycoprotein G Epitope-Based Peptide Vaccine in Mice., PMID:40333318

An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection., PMID:39217188

Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein., PMID:39134522

A Luciferase Immunosorbent Assay Based on Attachment Glycoprotein for the Rapid and Easy Detection of Nipah Virus IgG Antibodies., PMID:38792812

Predicting the changes in neutralizing antibody interaction with G protein derived from Bangladesh isolates of Nipah virus: molecular dynamics based approach., PMID:37643003

Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system., PMID:36680637

Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates., PMID:34696372

Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice., PMID:32340278

A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice., PMID:31878180

Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera., PMID:31513861

Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody., PMID:30995971

Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs., PMID:29708971

Monomeric ephrinB2 binding induces allosteric changes in Nipah virus G that precede its full activation., PMID:28974687

Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response., PMID:27544586

Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus., PMID:24508193

Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines., PMID:23175762

Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens., PMID:22226962

Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach., PMID:21177820

Assembly and biological and immunological properties of Newcastle disease virus-like particles., PMID:20181713

Efficacy of DNA immunization with F and G protein genes of Nipah virus., PMID:17135518

[Generation of recombinant vaccinia virus expressing attachment glycoprotein of Nipah virus]., PMID:17037071

Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model., PMID:16840334

[Study of fusion protein and attachment glycoprotein of Nipah virus expressed in recombinant baculovirus]., PMID:16755921

Purification of the extra-cellular domain of Nipah virus glycoprotein produced in Escherichia coli and possible application in diagnosis., PMID:15707682

Nipah virus glycoprotein: production in baculovirus and application in diagnosis., PMID:15522449

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-Nipah virus/NiV G protein/Glycoprotein G Antibody (nAH1.3) [VVV07901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only